For patients
Our multidisciplinary team is dedicated to providing comprehensive care, from accurate diagnosis to advanced treatment options.
More than 90,000 Americans face the diagnosis of a brain tumor each year. We're one of the leading referral centers nationally and deliver comprehensive treatments to more patients than nearly all other academic medical centers.
Brain tumors are characterized by abnormal cell growth in or around your brain. A mass can be small or large and can either be a benign tumor (noncancerous) or a malignant tumor (cancerous).
Each year, more than 90,000 Americans will face the life-changing diagnosis of a brain tumor. At the forefront of treating this condition is UF Health, one of the leading referral centers nationally. We deliver comprehensive, personalized treatments to more patients than nearly all other academic medical centers.
Our distinguished researchers and their teams collaborate daily with physicians who have dedicated their careers to finding a cure for brain cancer. Together, they use the latest molecular, biological, medical and surgical techniques to understand the fundamental causes of brain tumors and develop new treatment methods.
Have you recently been diagnosed with a brain tumor? Do you have questions? Make sure you have all the facts and understand all of your options.
Our multidisciplinary team is dedicated to providing comprehensive care, from accurate diagnosis to advanced treatment options.
Our colleagues from outside the UF Health system play a very valuable role in our mission.
The neuro-oncology team at UF Health consists of many highly skilled specialists working together to develop and deliver the most optimal treatment plans for you or your loved one.
Clinical trials can offer a new option, and many times, a new option equals hope.
Watch how Duane Mitchell, MD, PhD, and his team at the Preston A. Wells Jr. Center for Brain Tumor Therapy at the University of Florida have developed one of the most comprehensive clinical and research centers for advancing brain tumor treatment and discovering novel approaches.
Neurosurgery and neuroscience/neurology research at UF each ranked No. 2 in the country for NIH funding in 2025, according to newly published rankings by the Blue Ridge Institute for Medical Research. Among neurosurgery principal investigators nationwide, UF faculty members took the top two spots: Brian Hoh, MD, MBA, chair of neurosurgery, was No. 1 with $8.1 million in funding, while Dr. Mitchell, co-director of UF’s Preston A. Wells Jr. Center for Brain Tumor Therapy, was second with $5.9 million.
UF researchers discovered that patients with advanced lung or skin cancer who received a COVID-19 mRNA vaccine around the time they started immunotherapy tended to live longer than those who did not. This breakthrough study suggests the vaccine may help “boost” the body’s immune response, potentially making immunotherapy more effective. While more research is needed, these findings offer hope and may help doctors consider the best timing of treatments to improve patient outcomes.
UF researchers have developed a new imaging method that lets doctors safely track immune cells in real time after dendritic cell therapy, helping them see whether the cells reach the tumor without extra procedures. Created at the UF Preston A. Wells Jr. Center for Brain Tumor Therapy, this technology gives doctors a clearer view of how treatments are working and could eventually help speed the development of new immunotherapies and tailor care for patients with brain tumors and other neurological cancers.
UF and UF Health are using AI to advance new treatments, supported by HiPerGator, one of the world’s fastest supercomputers. Through the Digital Brain Initiative, they are making 1.4 million de-identified brain scans linked to clinical data available to researchers. This large dataset will help scientists study neurologic conditions such as tumors, Alzheimer’s disease and movement disorders, aiming to improve understanding and support the development of more precise diagnostics and therapies.
1.4% of newly diagnosed cancers are primary brain tumors
2.4% of cancer-related deaths are caused by brain tumors
Nearly half of all primary brain tumors are gliomas
80% of gliomas are considered grade three or four, which are fast-growing
The average age for developing primary brain tumors is 59
There are more than 120 different types, and they can be classified in many ways, one of which is based on their origin and behavior:
They can also be classified by histology:
Each type presents unique challenges and requires specialized treatment approaches.
Symptoms vary depending on the tumor's size, location, and growth rate. Common warning signs include:
If you experience persistent or worsening symptoms, please seek medical attention immediately.
The exact cause of most brain tumors remains unknown. However, certain factors may increase risk and understanding these factors aids in assessing individual risk profiles.
*Findings are inconsistent.
Accurate diagnosis is essential for effective treatment planning. At UF Health, our specialists employ advanced diagnostic tools, including:
These methods ensure a comprehensive evaluation of each case.
Our treatment strategies are tailored to the individual's specific tumor type and overall health. UF Health’s care options include:
UF Health’s MEG scanner at the Norman Fixel Institute for Neurological Diseases is one of only a few in the U.S. It provides noninvasive, highly precise mapping of brain activity to help doctors see tumor boundaries and protect important functions such as speech and movement during surgery for glioblastoma. When combined with advanced MRI in the Dorothy M. Mangurian Neuroimaging Suite, MEG helps guide safer tumor removal and can support faster access to targeted clinical trials.
Our multidisciplinary team collaborates to develop personalized treatment plans, ensuring optimal outcomes. For patients, here’s what to expect when you visit UF Health.
UF Health Shands Hospital is nationally recognized for excellence in neurology and neurosurgery, with U.S. News & World Report ranking us among the top hospitals in the country in this field. More specifically, our commitment to leading-edge research, the latest technology and compassionate care make us leaders in brain tumor treatment.
However, those are just some of the many ways UF Health stands out when it comes to brain tumor treatment:
We understand the emotional and psychological impact of a brain tumor diagnosis. UF Health offers comprehensive support services, including counseling, support groups and rehabilitation programs, to assist patients and their families throughout the treatment journey.
We are proud to care for patients at UF Health Shands Hospital, which is among the nation’s top hospitals for neurology and neurosurgery in the U.S. News & World Report 2026-2027 Best Hospital rankings.
UF Health research scientists make medicine better every day. They discover new ways to help people by running clinical trials. When you join a clinical trial, you can get advanced medical care. Sometimes years before it's available everywhere. You can also help make medicine better for everyone else. If you'd like to learn more about clinical trials, visit our clinical trials page. Or click one of the links below:
This is a 3-part study. The purpose of Part 1 of the study is to evaluate the efficacy, safety, and pharmacokinetic (PK) characteristics of safusidenib in participants with recurrent/progressive IDH1-mutant World Health Organization (WHO) Grade 2 or…
In this study we are evaluating the safety and feasibility of the triple combination (TTFields, MLA, pembrolizumab) in adult patients diagnosed with recurrent or progressive glioblastoma (GBM) WHO Grade IV, IDH wild type or recurrent or progressive…
Our community and patient programs provide great value to patients, families and loved ones. People can find support, educational materials, expert consultants and more. In most instances, these programs are offered free of charge.
Offers a wide variety of music-based therapies from in-room performances to collaborative recording sessions.
Pain management treatment plans for cancer patients.
The symposium will highlight new and emerging treatment strategies for brain tumor patients and cover a broad range of topics, including gliomas,…
Ocala resident Robin Feagle has done something truly remarkable: She completed the American Brain Tumor Association’s February walking challenge, logging 28…
February 22, 2019
The University of Florida has received a $12 million gift from Orlando hotel magnate Harris Rosen and The Harris Rosen Foundation to advance innovative brain…
AI at UF, College of Medicine, McKnight Brain Institute, +3 more